Literature DB >> 22212610

Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000 Jewish men.

Zohar Levi1, Jeremy D Kark, Arnon Afek, Estela Derazne, Dorit Tzur, Moshe Furman, Barak Gordon, Micha Barchana, Irena Liphshitz, Yaron Niv, Ari Shamiss.   

Abstract

PURPOSE: The increasing prevalence of adolescent obesity affects adult health. We investigated the association of adolescent overweight with pancreatic cancer incidence in a cohort of 720,927 Jewish Israeli men.
METHODS: Body mass index (BMI) was measured during a general health examination at ages 16-19 between the years 1967 and 1995. Overweight was defined as BMI ≥ 85th percentile of the reference US-CDC distribution in adolescence. Pancreatic cancer was identified by linkage with the Israel National Cancer Registry up to 2006.
RESULTS: The mean follow-up period was 23.3 ± 8.0 years. During 16.8 million person-years, 98 cases of pancreatic cancer were detected. Using Cox proportional hazards modeling, overweight in adolescence predicted an increased risk of pancreatic cancer [hazard ratio (HR) = 2.09; 95% confidence interval (CI): 1.26-3.50, p = 0.005]. Compared with adolescents with 'normal' range BMI Z-scores (-1 to +1), adolescents with Z-scores > 1 showed significantly increased risk [HR, 2.28 (95% CI: 1.43-3.64), p = 0.001]. Lower education level (10 or less years of schooling vs. 11-12 years) was also associated with increased risk of pancreatic cancer [HR 1.90 (95% CI: 1.27-2.86, p = 0.002)], whereas height, country of origin and immigration status were not.
CONCLUSIONS: Adolescent overweight is substantially associated with pancreatic cancer incidence in young to middle-aged adults. Applying our point estimates to the 16.8% prevalence of excess weight in Israeli adolescents in the past decade suggests a population fraction of 15.5% (95% CI: 4.2-29.6%) for pancreatic cancer attributable to adolescent overweight in Israel.

Entities:  

Mesh:

Year:  2012        PMID: 22212610     DOI: 10.1007/s10552-011-9886-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  9 in total

Review 1.  Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Authors:  Rachael Z Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Hematol Oncol Clin North Am       Date:  2015-08       Impact factor: 3.722

2.  Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.

Authors:  Rachael Z Stolzenberg-Solomon; Catherine Schairer; Steve Moore; Albert Hollenbeck; Debra T Silverman
Journal:  Am J Clin Nutr       Date:  2013-08-28       Impact factor: 7.045

3.  Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents.

Authors:  Gilad Twig; Avi Livneh; Asaf Vivante; Arnon Afek; Ari Shamiss; Estela Derazne; Dorit Tzur; Ilan Ben-Zvi; Amir Tirosh; Micha Barchana; Tamy Shohat; Eliezer Golan; Howard Amital
Journal:  Ann Rheum Dis       Date:  2013-03-16       Impact factor: 19.103

4.  Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes.

Authors:  Deborah L Kendall; Rakesh Amin; Peter E Clayton
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

Review 5.  Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention.

Authors:  Rick J Jansen; Xiang-Lin Tan; Gloria M Petersen
Journal:  Yale J Biol Med       Date:  2015-06-01

6.  Obesity at early adulthood increases risk of gastric cancer from the Health Examinees-Gem (HEXA-G) study.

Authors:  Hwi-Won Lee; Dan Huang; Woo-Kyoung Shin; Katherine de la Torre; Jae Jeong Yang; Minkyo Song; Aesun Shin; Jong-Koo Lee; Daehee Kang
Journal:  PLoS One       Date:  2022-02-04       Impact factor: 3.240

7.  Childhood body mass index and risk of adult pancreatic cancer.

Authors:  Leticia Nogueira; Rachael Stolzenberg-Solomon; Michael Gamborg; Thorkild I A Sørensen; Jennifer L Baker
Journal:  Curr Dev Nutr       Date:  2017-09-14

8.  From Population Databases to Research and Informed Health Decisions and Policy.

Authors:  Yossy Machluf; Orna Tal; Amir Navon; Yoram Chaiter
Journal:  Front Public Health       Date:  2017-09-21

9.  Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age.

Authors:  David T Chao; Nilesh H Shah; Herbert J Zeh; Aatur D Singhi; Nathan Bahary; Kevin M McGrath; Kenneth E Fasanella; Amer H Zureikat; David C Whitcomb; Randall E Brand
Journal:  Gastroenterol Res Pract       Date:  2018-06-05       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.